Company description
Creative Biolabs antibody cysteine modification platform has the unprecedented ability to produce antibodies introduced free cysteine without disrupting any antigen-targeting capacity, stability or homogeneity, which cannot be otherwise produced in any other platform. Advantages include quality, stability, purity, rapidly delivery as well as reduced production and development cost. This service has a wide application including but not limited to molecular imaging, antibody-drug conjugations (ADCs) and diagnostics.
